James Swales

发表

Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.

A. Dunton, A. Russell, Á. McKnight, 2022, Journal of Clinical Virology.

ONCE-DAILY INDACATEROL PROVIDES EFFECTIVE BRONCHODILATION OVER 1 YEAR OF TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

S. Rennard, K. Chapman, B. Kramer, 2009 .

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.

J. Lötvall, A. Yorgancioglu, D. Mahler, 2010, American journal of respiratory and critical care medicine.

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.

Richard Casaburi, R. Casaburi, D. O’Donnell, 2011, Respiratory medicine.